Phosphate binder

The product portfolio of Vifor Pharma also includes an iron based phosphate binder:

Velphoro® (Polynuclear Iron (III)-Oxyhydroxide, Sucroferric Oxyhydroxide)
Velphoro® is a non-calcium, iron based chewable phosphate binder for the control of serum phosphorus levels in adult patients with Chronic Kidney Disease (CKD) on dialysis treatment (haemodialysis or peritoneal dialysis). The recommended starting dose of Velphoro® is 3 tablets per day (1 tablet per meal), and Velphoro® could therefore help to improve phosphate management in these patients. Velphoro® was developed by Vifor Pharma and is produced in Switzerland. The rights of Velphoro® are with Vifor Fresenius Medical Care Renal Pharma. Depending on the country the distribution is done through either Vifor Pharma or Fresenius Medical Care.

For more information please visit


Vifor Pharma Ltd.

Flughofstrasse 61
P.O. Box
CH-8152 Glattbrugg

+41 58 851 80 00
+41 58 851 80 01

Send link

Send as link